Evaluate the Predictive Impact of the EHMRG

Heart Diseases Clinical Trial

— EHMRGscore  

Official title:

Evaluate the Predictive Impact of the EHMRG Score for Patients Admitted to the Emergency Department With Final Diagnosis of Acute Heart Failure

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05632263
• Other study ID #: EHMRG_MIR
• Status: Not yet recruiting
• Start date: April 30, 2023
• Est. completion date: December 15, 2023

Study information

• Verified date: March 2023
• Source: University of Monastir
• Contact: Nouira semir, Pr
• Phone: 73106046
• Email: semir.nouira[@]rns.tn
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

External validation of the EHMRG score for hospitalized patients with acute heart failure in the emergency department

Description:

It is a prospective cohort study carried out in the ED of Monastir which included patients admitted to the ED with a discharge diagnosis of AHF.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 1500
• Est. completion date: December 15, 2023
• Est. primary completion date: November 30, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 95 Years

Eligibility

Inclusion Criteria:

• Patients consulted for acute dyspnea and were diagnosed with acute heart failure.
• Major patient.
• Subject who accept to participate in the research.

Exclusion Criteria:

• Patient who refuse to participate in the study.
• Impossibility of giving the patient informed information

Related Conditions & MeSH terms

• Emergencies
• Heart Diseases

Intervention

Diagnostic Test:
• EHMRGscore
validation of the EHMRG score for hospitalized patients with acute heart failure in the emergency department

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
University of Monastir

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	EHMRGscore	The primary outcome of interest is the EHMRG predictive accuracy to prognosticate 7-day mortality was measured by the athe area under the receiver operating characteristic curver (AUROC) with 95% confidence intervals.	7days
Secondary	Re-admission rate 30-day re-admission rate	30day ré-admission rate	30days
Secondary	Mortality rate Mortality rate at 30 days	Mortality rate at 30 days	30day